Record Growth in Global Tourism Escalates Travel Vaccine Market over the Forecast Period (2019-2025) - Press Release - Digital Journal

-

A recent report published by Infinium Global Research on the travel vaccine market provides an in-depth analysis of segments and sub-segments in the global as well as the regional travel vaccine industry

This press release was orginally distributed by SBWire

Pune, India -- (SBWIRE) -- 11/27/2019 -- Infinium Global Research has added a new report on "Travel Vaccine Market (Composition - Mono Vaccine, and Combination Vaccines; Type - Attenuated Vaccines, Inactive Vaccines, Subunit Vaccines, Toxoid Vaccines, Conjugate Vaccines, DNA Vaccines, and Recombinant Vector Vaccines): Global Industry Analysis, Trends, Size, Share and Forecasts to 2025". Travel vaccines, also called travel immunizations shots travelers should get before visiting certain areas of the world that help protect them from serious illnesses. The global travel vaccine market was approximately valued at US$ 4.8 billion in 2018. It is anticipated to expand at a CAGR of 9.2% from 2019 to 2025 and is projected to reach US$ 8.68 billion during the forecast year of 2025.

Get Sample Report Copy for Market Insights @ https://www.infiniumglobalresearch.com/reports/sample-request/15258

Technological Advancement, Awareness Programs, Pandemic Diseases Provide Greater Opportunities for the Growth

The travel vaccine market is expected to grow at a substantial rate worldwide due to the appreciable growth in the tourism industry. As per the UN World Tourism Organization, international tourist arrival has increased to 1.4 billion in 2018. Global tourism hits record as affordable travel expenses, digitalization, new business models and visa facilitation made traveling easier thereby, boosting the travel vaccine market. Globalization is also one of the factors that fuel the growth of the travel vaccine market. However, high maintenance costs, stringent government policies and inefficient expertise for vaccine production may hamper the growth of the market. Despite the headwinds, the market is expected to witness substantial growth opportunities over the forecast period due to technological advancement, awareness programs, pandemic diseases.

Combination Vaccine Segment is Expected to Grow During the Forecast Period

The travel vaccine market can be divided based on composition and types. Based on the composition the travel vaccine market can be further segmented into a mono vaccine and combination vaccines. Owing to the vast use, the combination vaccine segment is expected to grow with a significant rate during the forecast period, as the combination vaccine can be used to cure diphtheria, tetanus & pertussis, and increase immune compliance, in a single dose of vaccine. Furthermore, based on vaccine type the market can be bifurcated into attenuated vaccines, inactive vaccines, subunit vaccines, toxoid vaccines, conjugate vaccines, DNA vaccines, and recombinant vector vaccines.

Request a Discount on Standard Prices of this Premium Report @ https://www.infiniumglobalresearch.com/reports/request-discount/15258

North America Holds the Largest Share

Geographically, the travel vaccine market is segmented into North America, Europe, Asia Pacific, and Row. North America dominates the market followed by Europe owing to its beneficial reimbursement policies and the dwelling of key players in this region. The market in Europe tends to grow due to the rise in awareness of the diseases and research on the development of disease-specific vaccines. Asia Pacific market is expected to have substantial growth in the forecast period as a result of the increasing prevalence of people traveling abroad and raising funds for vaccine development.

Travel Vaccine Market: Competitive Analysis

Some of the major key players operating in travel vaccine market are GlaxoSmithKline plc, Pfizer Inc., F. Hoffman-La Roche Ltd., Merck & Co., Inc., Abbott Laboratories, Sanofi S.A, Dynavax Technologies Corporation, Shenzhen Kangtay Biological Products Co., Baxter International, Takeda Pharmaceuticals U.S.A., Inc., and others. GlaxoSmithKline plc, Merck & Co., Inc, Pfizer Inc., and Sanofi S.A. are the global players leading the travel vaccine market. Zydus Cadila and Serum Institute of India are other key players operating in the Asia-Pacific region.

Browse Detailed TOC and Description of "Travel Vaccine Market"

Reasons to Buy this Report:

=> Comprehensive analysis of global as well as regional markets of the travel vaccine.

=> Complete coverage of all the product type and application segments to analyze the trends, developments, and forecast of market size up to 2025.

=> Comprehensive analysis of the companies operating in this market. The company profile includes analysis of product portfolio, revenue, SWOT analysis and the latest developments of the company.  

=> Infinium Global Research- Growth Matrix presents an analysis of the product segments and geographies that market players should focus to invest, consolidate, expand and/or diversify.

For more information on this press release visit: http://www.sbwire.com/press-releases/record-growth-in-global-tourism-escalates-travel-vaccine-market-over-the-forecast-period-2019-2025-1266246.htm



https://ift.tt/2rAMpqc

Comments

Post a Comment

Popular posts from this blog

Силы специальных операций будут выполнять задачи как за ...

-
Image
clindamycin gel pregnancy :: Article Creator Maternal Vs. Fetal Rights Forcing Pregnant Women to do as They're Told:Maternal vs. Fetal Rights By Claire Andre and Manuel Velasquez Janet Rowen may be incarcerated because she is pregnant. Her doctor, Marion Smyth, thinks Janet drinks too much alcohol and has repeatedly advised her of the risks her drinking poses to the child she has chosen to have. Heavy alcohol use during pregnancy can result in "fetal alcohol syndrome." Infants with this syndrome suffer from mental retardation and physical deformities and have an increased chance of dying shortly after birth. Janet is unwilling to cut down on her drinking. Dr. Smyth is seeking a court order that would incarcerate Janet for the duration of her pregnancy, forcing her to follow Dr. Smyth's medical advice. Research in medicine continues to reveal more and more ways in which a baby's health can be jeopardized by what a woman doe...
Read more

Providence says it offered to manage API before state awarded no-bid contract to Wellpath - Anchorage Daily News

-
Image
Alaska health care giant Providence Health and Services made overtures to the state about taking over management of the troubled Alaska Psychiatric Institute before a lucrative no-bid contract was awarded to Wellpath , a Tennessee-based company that sprouted from the private prison industry, a letter between hospital executives and lawmakers shows. In early February, Wellpath was awarded a roughly $43 million-per-year contract to operate API, the state’s only psychiatric hospital. State officials declared an emergency and circumvented the usual government procurement rules, saying the hospital was unsafe and about to lose federal funding. Ever since, questions about how the deal came together have dogged state health officials. Some lawmakers, like Rep. Ivy Spohnholz, an Anchorage Democrat, have asked why in-state providers like Providence were not considered. “Given that Providence has been operating in Alaska since 1902 and has a proven track record providing in-patient p...
Read more